GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

DARPA, Algorithms, Health Equity Corey Hubbard DARPA, Algorithms, Health Equity Corey Hubbard

The Hidden Danger: How AI Bias in Healthcare Can Harm Patients, and 15 Ways to Fix It

Artificial intelligence (AI) is rapidly moving from science fiction into everyday clinical settings and public health systems, especially with its accelerated use during the COVID-19 pandemic. These sophisticated applications, such as machine learning and deep learning, have enormous potential to revolutionize medicine, making care fairer and better overall. However, this powerful technology carries an enormous risk: if AI systems are not carefully designed, deployed, and monitored, they can deepen or reinforce existing health inequalities.

Read More
DARPA, AI/ML, Algorithms Corey Hubbard DARPA, AI/ML, Algorithms Corey Hubbard

Stop Digging: Why AI and Machine Learning Are Making Traditional Mining Obsolete.

The global mining industry faces relentless pressure to "do more with less," struggling to meet massive material demands while constrained by costs, resource scarcity, and safety imperatives. In response, a powerful new technological revolution is sweeping through the sector: Artificial Intelligence (AI). This is not merely an incremental improvement; it is a fundamental redefinition of how minerals are found, extracted, processed, and transported. Technologies like machine learning (ML), deep learning

Read More
ChatGPT, LLMs, Digital Innovation, NSF Corey Hubbard ChatGPT, LLMs, Digital Innovation, NSF Corey Hubbard

$0.93$ or $0.05$? How to Get GPT-4 Results Without Going Broke (The Secret Life of Budget AI Agents)

The rise of Large Language Models (LLMs) has revolutionized how we approach complex computational tasks, including generating intricate code snippets. These powerful AI tools are adept at a vast array of applications, from natural language processing to complex code development

Read More
Creativity, Algorithms, DARPA Corey Hubbard Creativity, Algorithms, DARPA Corey Hubbard

Mobile AI Chaos Solved? M4's Firmware-Like LLM Brain Takes Control!

Tired of fragmented mobile AI? Meet M4, the pioneering OS-hardware co-managed foundation model acting like firmware for your smartphone! This LLM-powered solution tackles 38+ diverse tasks across vision, language, audio, and multimodal inputs with accuracy parity in 85% of cases. M4 dramatically simplifies NPU design and boosts on-device intelligence and data privacy, overcoming the "ad-hoc" mess with lightweight "adapters" and significantly fewer operators. Get ready for mobile AI that finally makes sense!

Read More
Digital Innovation, Algorithms, DARPA Corey Hubbard Digital Innovation, Algorithms, DARPA Corey Hubbard

Supercharging AI Startups: Unleashing the Power of Atom-Searcher for Next-Gen Deep Research

In the rapidly evolving landscape of artificial intelligence, Large Language Models (LLMs) have demonstrated astonishing abilities in understanding language and performing logical reasoning. However, when faced with truly complex problems that demand up-to-date or specialized knowledge, these models often hit a wall because their internal knowledge is static, like a library that hasn't been updated in years. To overcome this, a technique called Retrieval-Augmented Generation (RAG) emerged

Read More
Digital Innovation, Higher Education, SAT Corey Hubbard Digital Innovation, Higher Education, SAT Corey Hubbard

Taming Tardiness: How "Project TARDI" Transformed Student Punctuality and Boosted Learning

Student tardiness and absenteeism are persistent challenges that plague educational institutions worldwide, often acting as silent saboteurs of academic performance and overall school success. These issues don't just affect individual students; they disrupt classrooms, hinder teaching flow, and ultimately impede a school's ability to fulfill its core mission of providing quality education. In the Philippines, particularly at Mataas na Paaralang Neptali A. Gonzales

Read More
GreenTech, DARPA, Clinical Trials Corey Hubbard GreenTech, DARPA, Clinical Trials Corey Hubbard

Building a Greener Future: How AI and Smart Tech are Making Biofabrication Sustainable

Imagine a world where we can grow human tissues for transplants, create new materials from living cells, and even develop bio-robots, all while being kind to our planet. This vision is at the heart of biofabrication, a fascinating and rapidly evolving field that blends biology, materials science, medicine

Read More
Algorithms, Genotype, Proteins Corey Hubbard Algorithms, Genotype, Proteins Corey Hubbard

Bio-AI Revolution: Data-Driven Design & Engineering of Synthetic Cell Factories for Industrial Biomanufacturing

This review explores the transformative impact of data-driven Artificial Intelligence (AI) and Machine Learning (ML), including Deep Learning, on synthetic biology and industrial biomanufacturing. It details applications in the design and engineering of novel enzymes and proteins, reconstruction and improvement of metabolic models

Read More
Digital Innovation, DARPA, Algorithms, Nvidia Corey Hubbard Digital Innovation, DARPA, Algorithms, Nvidia Corey Hubbard

Artificial Intelligence Unleashed: Navigating the Global Impact and Future Landscape

Artificial Intelligence (AI) is no longer a concept confined to science fiction; it is a transformative technology deeply woven into the fabric of our daily lives, fundamentally altering how we interact with the world around us. Defined as an academic discipline focused on developing computer systems and robots that possess human-like intelligence, including cognitive powers

Read More
Clinical Trials, Innovation, Algorithms Corey Hubbard Clinical Trials, Innovation, Algorithms Corey Hubbard

AI Flips the Script: Pharma's R&D Just Got a Supercharge (Bye, Eroom's Law!)

Get ready for a paradigm shift in biopharma! Artificial Intelligence (AI) is rapidly revolutionizing drug discovery, development, manufacturing, and delivery, promising to drastically reduce the time and cost traditionally associated with bringing new medicines to market. Forget the old narrative of Eroom's Law; AI is ushering in an era where innovative treatments can reach patients faster and more efficiently

Read More

AI-Designed Oral GLP-1RA Shows Promise in Weight Loss

In the ongoing global health challenge of obesity and its associated conditions, the search for effective and convenient treatments is paramount. Recently, a significant breakthrough has emerged from China-based MindRank, a biotech company that has reported promising results from its Phase IIb clinical trial for an oral medication known as MDR-001.

Read More
Algorithms, Technology, Digital Age Corey Hubbard Algorithms, Technology, Digital Age Corey Hubbard

The concept of "fairness" in algorithms is a complex and increasingly critical topic

At its core, an algorithm is a set of rules or instructions that a computer follows to perform a task or solve a problem. In the context of AI, these algorithms often "learn" from vast amounts of data to make predictions or decisions. For example, a machine learning algorithm might be trained on historical loan application data to decide who qualifies for a loan

Read More
Therapuetics, Clinical Trials, Cancer, Technology Corey Hubbard Therapuetics, Clinical Trials, Cancer, Technology Corey Hubbard

Lung Cancer's New Friend: Why AI Is the Ultimate Partner

Discover how Artificial Intelligence (AI) is revolutionizing lung cancer care, from early detection and accurate diagnosis to personalized treatment decisions and prognosis prediction. AI systems enhance the reading of low-dose CT (LDCT) and chest X-rays (CXR), significantly improving nodule detection accuracy and reducing radiologist workload. Explore AI's role in analyzing whole slide imaging (WSI) for histopathological insights and predicting molecular features like gene mutations and PD-L1 expression. This comprehensive approach, integrating radiomics, genomics, and clinical data, holds promise for optimizing lung cancer screening, diagnosis, and patient outcomes in the future.

Read More